OGEN Insider Trading Activity and SEC Form 4 Filings
OGEN insider trading summary
Over the past 12 months, insiders at Oragenics Inc (OGEN) reported 2 sales worth $397 by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $397.
Latest OGEN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Fred Telling | Director | Sell | $198 (210 @ $0.94) |
| Dec 12, 2025 | Fred Telling | Director | Sell | $198 (210 @ $0.94) |
| Jun 18, 2025 | Odyssey Health, Inc. | 10% Owner | Sell | $21K (5,044 @ $4.26) |
| Jun 17, 2025 | Odyssey Health, Inc. | 10% Owner | Sell | $9K (2,000 @ $4.46) |
| Jun 16, 2025 | Odyssey Health, Inc. | 10% Owner | Sell | $22K (5,000 @ $4.45) |
| Jun 13, 2025 | Odyssey Health, Inc. | 10% Owner | Sell | $21K (5,000 @ $4.27) |
| Dec 6, 2024 | Alan W Dunton | Director | Sell | $24 (66 @ $0.36) |
| Dec 6, 2024 | Fred Telling | Director | Sell | $1K (3,597 @ $0.36) |
| Nov 30, 2023 | Fred Telling | Director | Sell | $12K (3,500 @ $3.57) |
| Dec 30, 2022 | Robert C Koski | Director | Sell | $4K (42,357 @ $0.11) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.